Last deal

$801.5K
Local Amount - EUR 800.K

Amount

Corporate Round

Stage

09.11.2022

Date

2

all rounds

$801.5K

Total amount

General

About Company
Promed Bioscience provides highly purified research and medical grade collagen from animal tissue.

Industry

Sector :

Subsector :

Also Known As

Promed

founded date

2017

Number of employees

Company Type

For Profit

Last funding type

Corporate Round

IPO status

Private

Description

The company produces and supplies carefully controlled collagen products for a wide range of research, clinical, and cosmetic applications. Their collagen-based biomaterials are used to create gels for cell culture, scaffolds for tissue engineering, and assays that study cell behavior and interactions with the extracellular environment. Promed Bioscience's purified medical-grade atelocollagen from animal tissue is distributed internationally, helping medical professionals and researchers combat the breakdown and loss of connective tissue caused by daily wear and tear, injury, or disease.
Contacts